Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Liselotte Højgaard:

The European Cancer Patient's Bill of Rights, update and implementation 2016. Højgaard L et al. ESMO Open. (2016)

[Biomarkers for early diagnosis of Alzheimer's disease]. Frederiksen KS et al. Ugeskr Laeger. (2015)

<sup>18</sup> F-FDG PET/CT for planning external beam radiotherapy alters therapy in 11% of 581 patients. Birk Christensen C et al. Clin Physiol Funct Imaging. (2018)

Search results

Items: 1 to 20 of 116

1.

Quantifying the Financial Savings of Motion Correction in Brain MRI: A Model-Based Estimate of the Costs Arising From Patient Head Motion and Potential Savings From Implementation of Motion Correction.

Slipsager JM, Glimberg SL, Søgaard J, Paulsen RR, Johannesen HH, Martens PC, Seth A, Marner L, Henriksen OM, Olesen OV, Højgaard L.

J Magn Reson Imaging. 2020 Mar 7. doi: 10.1002/jmri.27112. [Epub ahead of print]

PMID:
32144848
2.

Early Postoperative 18F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors.

Marner L, Nysom K, Sehested A, Borgwardt L, Mathiasen R, Henriksen OM, Lundemann M, Munck Af Rosenschöld P, Thomsen C, Bøgeskov L, Skjøth-Rasmussen J, Juhler M, Kruse A, Broholm H, Scheie D, Lauritsen T, Forman JL, Wehner PS, Højgaard L, Law I.

J Nucl Med. 2019 Aug;60(8):1053-1058. doi: 10.2967/jnumed.118.220293. Epub 2019 Jan 25.

PMID:
30683767
3.

Deep Learning Based Attenuation Correction of PET/MRI in Pediatric Brain Tumor Patients: Evaluation in a Clinical Setting.

Ladefoged CN, Marner L, Hindsholm A, Law I, Højgaard L, Andersen FL.

Front Neurosci. 2019 Jan 7;12:1005. doi: 10.3389/fnins.2018.01005. eCollection 2018.

4.

Hybrid PET/MRI imaging in healthy unsedated newborn infants with quantitative rCBF measurements using 15O-water PET.

Andersen JB, Lindberg U, Olesen OV, Benoit D, Ladefoged CN, Larsson HB, Højgaard L, Greisen G, Law I.

J Cereb Blood Flow Metab. 2019 May;39(5):782-793. doi: 10.1177/0271678X17751835. Epub 2018 Jan 15.

5.

The European Cancer Patient's Bill of Rights, update and implementation 2016.

Højgaard L, Löwenberg B, Selby P, Lawler M, Banks I, Law K, Albreht T, Armand JP, Barbacid M, Barzach M, Bergh J, Cameron D, Conte P, de Braud F, de Gramont A, De Lorenzo F, Diehl V, Diler S, Erdem S, Geissler J, Gore-Booth J, Henning G, Horgan D, Jassem J, Johnson P, Kaasa S, Kapitein P, Karjalainen S, Kelly J, Kienesberger A, La Vecchia C, Lacombe D, Lindahl T, Luzzatto L, Malby R, Mastris K, Meunier F, Murphy M, Naredi P, Nurse P, Oliver K, Pearce J, Pelouchov J, Piccart M, Pinedo B, Spurrier-Bernard G, Sullivan R, Tabernero J, Van de Velde C, van Herk B, Vedsted P, Waldmann A, Weller D, Wilking N, Wilson R, Yared W, Zielinski C, Zur Hausen H, Le Chevalier T, Johnston P.

ESMO Open. 2017 Jan 6;1(6):e000127. doi: 10.1136/esmoopen-2016-000127. eCollection 2016. Review.

6.

RESOLUTE PET/MRI Attenuation Correction for O-(2-18F-fluoroethyl)-L-tyrosine (FET) in Brain Tumor Patients with Metal Implants.

Ladefoged CN, Andersen FL, Kjær A, Højgaard L, Law I.

Front Neurosci. 2017 Aug 11;11:453. doi: 10.3389/fnins.2017.00453. eCollection 2017.

7.

A Prospective Study Comparing 99mTc-Hydroxyethylene-Diphosphonate Planar Bone Scintigraphy and Whole-Body SPECT/CT with 18F-Fluoride PET/CT and 18F-Fluoride PET/MRI for Diagnosing Bone Metastases.

Löfgren J, Mortensen J, Rasmussen SH, Madsen C, Loft A, Hansen AE, Oturai P, Jensen KE, Mørk ML, Reichkendler M, Højgaard L, Fischer BM.

J Nucl Med. 2017 Nov;58(11):1778-1785. doi: 10.2967/jnumed.116.189183. Epub 2017 Aug 10.

8.

18 F-FDG PET/CT for planning external beam radiotherapy alters therapy in 11% of 581 patients.

Birk Christensen C, Loft-Jakobsen A, Munck Af Rosenschöld P, Højgaard L, Roed H, Berthelsen AK.

Clin Physiol Funct Imaging. 2018 Mar;38(2):278-284. doi: 10.1111/cpf.12411. Epub 2017 Feb 6.

PMID:
28168798
9.

A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System.

Beliveau V, Ganz M, Feng L, Ozenne B, Højgaard L, Fisher PM, Svarer C, Greve DN, Knudsen GM.

J Neurosci. 2017 Jan 4;37(1):120-128. doi: 10.1523/JNEUROSCI.2830-16.2016.

10.

A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients.

Ladefoged CN, Law I, Anazodo U, St Lawrence K, Izquierdo-Garcia D, Catana C, Burgos N, Cardoso MJ, Ourselin S, Hutton B, Mérida I, Costes N, Hammers A, Benoit D, Holm S, Juttukonda M, An H, Cabello J, Lukas M, Nekolla S, Ziegler S, Fenchel M, Jakoby B, Casey ME, Benzinger T, Højgaard L, Hansen AE, Andersen FL.

Neuroimage. 2017 Feb 15;147:346-359. doi: 10.1016/j.neuroimage.2016.12.010. Epub 2016 Dec 14.

11.

Optimized MLAA for quantitative non-TOF PET/MR of the brain.

Benoit D, Ladefoged CN, Rezaei A, Keller SH, Andersen FL, Højgaard L, Hansen AE, Holm S, Nuyts J.

Phys Med Biol. 2016 Dec 21;61(24):8854-8874. Epub 2016 Dec 2.

PMID:
27910823
12.

Safety, Dosimetry, and Tumor Detection Ability of 68Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET Imaging.

Skovgaard D, Persson M, Brandt-Larsen M, Christensen C, Madsen J, Klausen TL, Holm S, Andersen FL, Loft A, Berthelsen AK, Pappot H, Brasso K, Kroman N, Højgaard L, Kjaer A.

J Nucl Med. 2017 Mar;58(3):379-386. doi: 10.2967/jnumed.116.178970. Epub 2016 Sep 8.

13.

Cross-calibration of the Siemens mMR: easily acquired accurate PET phantom measurements, long-term stability and reproducibility.

Keller SH, Jakoby B, Svalling S, Kjaer A, Højgaard L, Klausen TL.

EJNMMI Phys. 2016 Dec;3(1):11. doi: 10.1186/s40658-016-0146-3. Epub 2016 Jul 7.

14.

Simultaneous PET/MRI with (13)C magnetic resonance spectroscopic imaging (hyperPET): phantom-based evaluation of PET quantification.

Hansen AE, Andersen FL, Henriksen ST, Vignaud A, Ardenkjaer-Larsen JH, Højgaard L, Kjaer A, Klausen TL.

EJNMMI Phys. 2016 Dec;3(1):7. doi: 10.1186/s40658-016-0143-6. Epub 2016 Apr 22.

15.

PET/MR: improvement of the UTE μ-maps using modified MLAA.

Benoit D, Ladefoged C, Rezaei A, Keller S, Andersen F, Hojgaard L, Hansen AE, Holm S, Nuyts J.

EJNMMI Phys. 2015 Dec;2(Suppl 1):A58. doi: 10.1186/2197-7364-2-S1-A58. No abstract available.

16.

PET/MR attenuation correction in brain imaging using a continuous bone signal derived from UTE.

Ladefoged C, Benoit D, Law I, Holm S, Hojgaard L, Hansen AE, Andersen FL.

EJNMMI Phys. 2015 Dec;2(Suppl 1):A39. doi: 10.1186/2197-7364-2-S1-A39. No abstract available.

17.

In Vivo Phenotyping of Tumor Metabolism in a Canine Cancer Patient with Simultaneous (18)F-FDG-PET and Hyperpolarized (13)C-Pyruvate Magnetic Resonance Spectroscopic Imaging (hyperPET): Mismatch Demonstrates that FDG may not Always Reflect the Warburg Effect.

Gutte H, Hansen AE, Larsen MM, Rahbek S, Johannesen HH, Ardenkjaer-Larsen J, Kristensen AT, Højgaard L, Kjaer A.

Diagnostics (Basel). 2015 Jun 26;5(3):287-9. doi: 10.3390/diagnostics5030287.

18.

Positron Emission Tomography and Magnetic Resonance Imaging of the Brain in Fabry Disease: A Nationwide, Long-Time, Prospective Follow-Up.

Korsholm K, Feldt-Rasmussen U, Granqvist H, Højgaard L, Bollinger B, Rasmussen AK, Law I.

PLoS One. 2015 Dec 2;10(12):e0143940. doi: 10.1371/journal.pone.0143940. eCollection 2015.

19.

First-in-human uPAR PET: Imaging of Cancer Aggressiveness.

Persson M, Skovgaard D, Brandt-Larsen M, Christensen C, Madsen J, Nielsen CH, Thurison T, Klausen TL, Holm S, Loft A, Berthelsen AK, Ploug M, Pappot H, Brasso K, Kroman N, Højgaard L, Kjaer A.

Theranostics. 2015 Sep 13;5(12):1303-16. doi: 10.7150/thno.12956. eCollection 2015.

20.

Erratum to: Motion correction in simultaneous PET/MR brain imaging using sparsely sampled MR navigators: a clinically feasible tool.

Keller SH, Hansen C, Hansen C, Andersen FL, Ladefoged C, Svarer C, Kjær A, Højgaard L, Law I, Henriksen OM, Hansen AE.

EJNMMI Phys. 2015 Dec;2(1):23. doi: 10.1186/s40658-015-0126-z. No abstract available.

Supplemental Content

Loading ...
Support Center